Faculty receive $6.1M NIH grant for maternal health study
Three faculty from the Brown School and School of Medicine at Washington University in St. Louis have received a seven-year $6.1 million grant from the National Institutes of Health (NIH) for a project aimed at improving the health of mothers and children in the St. Louis region.
Drug combo therapy in mice blocks drug resistance, halts tumor growth
An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis and colleagues.
New technology offers pathways to finding treatments for kidney disease
Research from the McKelvey School of Engineering and School of Medicine aims to overcome a critical barrier in kidney disease research with a new way to culture specific kidney cells.
Push, pull or swirl: the many movements of cilia
Louis Woodhams and Phil Bayly’s team at the McKelvey School of Engineering built a model to better understand how certain cilia — tiny, hairlike structures throughout our body — beat.
WashU Medicine, BJC HealthCare partner with new company to accelerate lifesaving research
Washington University School of Medicine and BJC HealthCare are partnering with CuriMeta, a new company based in St. Louis, that will accelerate lifesaving research in the fight against chronic and acute diseases.
Study points to new approach to clearing toxic waste from brain
Washington University School of Medicine researchers have found a new druggable pathway, in mice, that potentially could be used to help prevent Alzheimer’s dementia.
Distress leads to higher COVID vaccine rates, less adherence to distancing guidelines
New research from the Department of Psychological & Brain Sciences in Arts & Sciences indicates that fear-based messaging may result in mixed effects when it comes to public health.
Modified nucleotides used in COVID-19 vaccines work as designed
Biologists in the laboratory of Hani Zaher in Arts & Sciences examined the modified nucleotides used in COVID-19 vaccines. The modifications faithfully produce the protein products as designed, a welcome sign for future RNA therapeutics.
Modeling personalized medicine for neurocritical illness
ShiNung Ching and collaborators are working with a $1 million NIH grant to predict and prevent some injuries related to neurological illnesses.
Study offers insights into how pancreatic cancer develops
A new study from Washington University School of Medicine has revealed the details of two key transition points in the development of pancreatic cancer. The study provides insights into treatment resistance and how immunotherapy could be harnessed to treat this aggressive tumor type.
Older Stories